Welcome Guest (Log in, Subscribe
 What's New | Home | About Us | Contact Us | Help Center | Publications | Site Map | Links | Subscription 

Last update:2012.04.04.
 Regulatory Basis  Forum Issues  Intelligence Services  Web Applications  21 CFR Part 11 Compliant Products 

Intelligence Services
21 CFR Part 11
Competency Training
Blend Uniformity
Patent databases

Adobe Acrobat Reader
Where are you now? Intelligence Services > Dissolution > Dissolution


Dissolution plays not only an important, but also a unique role in the pharmaceutical industry. It is an interface between in vitro and in vivo, that is between laboratory results and therapeutic results. The models for the interface are continuously refined, and during the past decades important evolutionary milestones have been achieved, such as specification of USP 3 and USP 4 apparatus and inclusion into compendia testing, or expansion of dissolution testing requirements for vitamins, or new FDA guidelines on the evaluation of dissolution similarities.

Demands for better and smarter software, instrumentation, and integrated technology are continuously growing. Our Web-site will include information, regulation, case-studies, and knowledge on:

  • Software & instrumentation,
  • Calibration,
  • DQ-IQ-OQ-PQ applications,
  • Case studies,
  • Modeling, and
  • Evolving technologies.
21 CFR Part 11 Issues
Various aspects of electronic records and electronic signatures
Forum Database
Almost 100,000 searchable messages from 16 working newsgroups. Updated regularly.
Warning Letters Knowledge Base
An extremely versatile database that will assist familiarization with the regulatory requirements
Competency Trainings & Exams
Multimedia enriched learning materials, exercises and exams.
On-line Trainings & Exams
Web-based learning materials, exercises and exams

back Back
--| What's New | Home | About Us | Contact Us | Help Center | Publications | Site Map | Links | Subscription |--
© 2001-2003 OPULUS® is licensed to BioMondex Ltd. All rights reserved. Please read the disclaimer.